Vimarsana
Biggest News Aggregation in the World

Page 21 - Pharma Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Services Today - Breaking & Trending Today

Mach 1 Financial Group LLC Takes $491,000 Position in NeoGenomics, Inc. (NASDAQ:NEO) - Vimarsana News

Mach 1 Financial Group LLC Takes $491,000 Position in NeoGenomics, Inc. (NASDAQ:NEO)

Mach 1 Financial Group LLC bought a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the second quarter, HoldingsChannel reports. The firm bought 30,541 shares of the medical research company’s stock, valued at approximately $491,000. Several other large investors also recently modified their holdings of the business. Cerity Partners LLC purchased […]

Illinois manufacturers visit Rockford to dispel image of industry as 'dark, dirty, and dangerous' - Vimarsana News

Illinois manufacturers visit Rockford to dispel image of industry as 'dark, dirty, and dangerous'

ROCKFORD, Ill. (WTVO) — The Illinois Manufacturer’s Association’s statewide bus tour stopped in Rockford on Wednesday to address stigma of working in manufacturing. The “Makers on the Move” stopped at PCI Pharma Services, at 4545 Assembly Drive, as part of a celebration of manufacturing. IMA is making over two dozen statewide in stops over 8 […]

European Healthcare Acquisition & Growth B : Halfjaarlijkse financiële verslaggeving -September 28, 2023 at 03:08 pm EDT - Vimarsana News

European Healthcare Acquisition & Growth B : Halfjaarlijkse financiële verslaggeving -September 28, 2023 at 03:08 pm EDT

HALF-YEAR REPORT 2023 European Healthcare Acquisition & Growth Company B.V. CONTENTS ...

Ypsomed signs autoinjector supply deal with Novo Nordisk - Vimarsana News

Ypsomed signs autoinjector supply deal with Novo Nordisk

(Reuters) -Swiss medical technology company Ypsomed announced on Wednesday a long-term supply deal with Novo Nordisk for autoinjectors, the latest sign of how the Danish drugmaker's weight-loss drug business is a boon for pharmaceutical services companies. Ypsomed said it would expand its manufacturing capacities over the coming years, with Novo Nordisk contributing a significant part of the investment for the additional production infrastructure. The autoinjectors will be used by people self-administering drugs to treat various metabolic indications, Ypsomed said, adding that the pens ...

Source: yahoo.com
Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | North America to account for 36% of market growth - Vimarsana News

Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | North America to account for 36% of market growth

/PRNewswire/ -- The clinical trial supplies market size is expected to grow by USD 1.19 billion from 2022 to 2027. In addition, the momentum of the market will...